ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,273Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 198

$844K Total Retail Price of All Prescriptions

Rank: 16 out of 198

504 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 13,259 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 747 707 1 1
FUROSEMIDE 575 519 2 5
OMEPRAZOLE 525 432 3 3
HYDROCODONE-ACETAMINOPHEN 448 382 S3 4 8
AMLODIPINE BESYLATE 445 387 5 4
WARFARIN SODIUM 397 365 6 7
METOPROLOL SUCCINATE 381 349 7 11
PRAVASTATIN SODIUM 355 323 8 19
POTASSIUM CHLORIDE 292 246 9 9
LISINOPRIL 292 257 9 6
METOPROLOL TARTRATE 288 260 11 10
SIMVASTATIN 265 249 12 2
METFORMIN HCL 253 220 13 13
CRESTOR 185 149 14 26
ENALAPRIL MALEATE 181 156 15 51
ATORVASTATIN CALCIUM 177 148 16 12
DIGOXIN 167 164 17 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 160 142 18 38
RANITIDINE HCL 152 95 19 54
CITALOPRAM HBR 149 149 20 20
GLIPIZIDE 142 135 21 62
ALLOPURINOL 138 126 22 23
GABAPENTIN 138 128 22 14
BISOPROLOL FUMARATE 132 112 24 87
ADVAIR DISKUS 128 111 25 47
CLOPIDOGREL 125 108 26 42
BOOSTRIX 116 105 27 221
DIOVAN 116 95 27 34
ALENDRONATE SODIUM 112 99 29 21
ATENOLOL 111 87 30 17
TRAMADOL HCL 110 92 31 15
NAMENDA 110 110 31 33
FENOFIBRATE 107 92 33 61
TAMSULOSIN HCL 105 92 34 27
SPIRONOLACTONE 101 97 35 37
ZOLPIDEM TARTRATE 97 77 36 22
METFORMIN HCL ER 96 56 37 64
CARBIDOPA-LEVODOPA 90 87 38 71
SPIRIVA 88 82 39 63
BYSTOLIC 85 76 40 58
ISOSORBIDE MONONITRATE ER 84 81 41 60
DONEPEZIL HCL 83 83 42 28
LOSARTAN POTASSIUM 82 72 43 18
PANTOPRAZOLE SODIUM 81 77 44 31
CARVEDILOL 79 67 45 24
LANTUS 77 77 46 46
JANUVIA 73 55 47 86
SERTRALINE HCL 71 55 48 25
PREDNISONE 71 60 48 29
SYMBICORT 70 59 50 150
GLYBURIDE 69 69 R 51 103
RAMIPRIL 67 67 52 72
RISPERIDONE 67 67 52 82
NOVOLIN N 64 57 54 201
PLAVIX 64 58 54 66
ZOSTAVAX 64 56 54 169
MELOXICAM 63 54 57 30
NEXIUM 61 44 58 40
HYDROCHLOROTHIAZIDE 61 61 58 16
LANSOPRAZOLE 61 44 58 166
CYMBALTA 60 36 61 48
CALCITRIOL 59 51 62 179
BENICAR 58 58 63 100
PROAIR HFA 57 40 64 80
ESCITALOPRAM OXALATE 57 42 64 53
POLYETHYLENE GLYCOL 3350 56 51 66 41
AZITHROMYCIN 55 43 67 56
FENTANYL 55 52 S2 67 73
FLUTICASONE PROPIONATE 54 47 69 39
NIASPAN 54 33 69 138
INSULIN SYRINGE 53 49 71 95
GLIPIZIDE ER 53 41 71 83
PEN NEEDLE 52 36 73 114
NOVOLOG 51 46 74 107
BENAZEPRIL HCL 50 50 75 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.